37 results
8-K
EX-99.2
MIRM
Mirum Pharmaceuticals Inc
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
, 2023. Direct Markets Net Product Sales Three commercial medicines Enhanced scale and focus in pediatric rare disease Model maximizes engagement
8-K
EX-2.1
MIRM
Mirum Pharmaceuticals Inc
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
force majeure event, or the escalation or worsening thereof, national or international political or social conditions, including the engagement by any … of employment or engagement with Purchaser or any Affiliate of Purchaser made prior to the Closing pursuant to this Agreement or otherwise); (h
8-K
EX-1.1
xm76crxbge
10 Aug 22
Other Events
12:00am
8-K
EX-99.2
2fnhgtv
11 Jan 22
Mirum Pharmaceuticals Provides Business Update and Highlights Key 2022 Corporate Milestones
9:00am
8-K
EX-1.1
bsv30t
15 Dec 20
Other Events
5:09pm
DEF 14A
zs6x5wd
29 Apr 20
Definitive proxy
4:15pm
10-K
lvz545g1g443c
12 Mar 20
Annual report
4:16pm
424B4
chaj02641 7dfwi
9 Jan 20
Prospectus supplement with pricing info
5:11pm